Search
Salafibrate
go.drugbank.com/drugs/DB20767ExperimentalSalafibrate is a small molecule drug. … The usage of the INN stem '-fibrate' in the name indicates that Salafibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Nicofibrate
go.drugbank.com/drugs/DB19916ExperimentalNicofibrate is a small molecule drug. … The usage of the INN stem '-fibrate' in the name indicates that Nicofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Dulofibrate
go.drugbank.com/drugs/DB20032ExperimentalDulofibrate is a small molecule drug. … The usage of the INN stem '-fibrate' in the name indicates that Dulofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Atigliflozin
go.drugbank.com/drugs/DB21394InvestigationalAtigliflozin is a small molecule drug. … Atigliflozin has a monoisotopic molecular weight of 382.11 Da.
Lifibrate
go.drugbank.com/drugs/DB21399ExperimentalLifibrate is a small molecule drug. … The usage of the INN stem '-fibrate' in the name indicates that Lifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Dazdotuftide
go.drugbank.com/drugs/DB21550InvestigationalDazdotuftide is a small molecule drug. … Dazdotuftide has a monoisotopic molecular weight of 1005.48 Da.
Muvalaplin
go.drugbank.com/drugs/DB21568InvestigationalMuvalaplin is a small molecule drug. … Muvalaplin has a monoisotopic molecular weight of 710.4 Da.
Pocenbrodib
go.drugbank.com/drugs/DB21616InvestigationalPocenbrodib is a small molecule drug. … Pocenbrodib has a monoisotopic molecular weight of 525.23 Da.
Elarofiban anhydrous
go.drugbank.com/drugs/DB21212ExperimentalElarofiban anhydrous is a small molecule drug. … Elarofiban anhydrous has a monoisotopic molecular weight of 416.24 Da.
Categories: Heterocyclic Compounds, 1-RingMaytansine
go.drugbank.com/drugs/DB19582InvestigationalMaytansine has a monoisotopic molecular weight of 691.29 Da. … Maytansine is a small molecule drug. Maytansine is under investigation in clinical trial NCT04189211 (A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients).